Vitamin IV at Home: Designed for patients managing fatigue, immune depletion, post-travel recovery, or nutritional ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...
Scientists have recently developed a therapy that uses bacteria to deliver viruses to destroy tumor cells. The treatment ...
Mayim Bialik said she experienced nightmare side effects on a GLP-1. Here's what happened.
Dosing of adults with early Alzheimer’s disease in clinical trial expected H2 2026 - LEXINGTON, Mass., June 01, 2026 (GLOBE ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
Disease activity, organ involvement, and treatment choice all shape infection risk in lupus and rheumatoid arthritis, with ...
Increased T-cell receptor clonality and novel clonotypes seen with intismeran plus pembrolizumab versus pembrolizumab alone.
Adding intismeran autogene to pembrolizumab reduces the risk of relapse and distant metastasis in patients with resected high ...
Ketamine is a drug often clouded by misunderstanding. While many associate it with illicit use, the pharmaceutical version ...
CAR T-cell therapy successfully cleared anti-HLA antibodies to enable kidney transplantation in three highly sensitized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results